We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.71B
1-Year Est. Return
65.19%
This Fund
S&P 500
This Quarter
Est. Return
+5.72%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.14B
AUM Growth
-$171M
(-5.2%)
Cap. Flow
-$231M
Cap. Flow
% of AUM
-7.38%
Top 10 Holdings %
Top 10 Hldgs %
16.05%
Holding
444
New
72
Increased
89
Reduced
94
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$29.5M |
| 2 |
Middleby
MIDD
|
+$25.9M |
| 3 |
Parker-Hannifin
PH
|
+$25.1M |
| 4 |
Veeva Systems
VEEV
|
+$23M |
| 5 |
Dick's Sporting Goods
DKS
|
+$22.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$43.4M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$35.2M |
| 3 |
TransDigm Group
TDG
|
+$29.9M |
| 4 |
Visa
V
|
+$28.6M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$22.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Energy | 16.11% |
| 3 | Healthcare | 14.04% |
| 4 | Industrials | 13.84% |
| 5 | Consumer Discretionary | 11.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Ingredion
INGR
$6.21B
| – | – |
-24,539
| Closed | -$3.27M |
|
402
KT
KT
$9.26B
| – | – |
-10,995
| Closed | -$176K |
|
403
Lennar Class A
LEN
$18.9B
| – | – |
-195,142
| Closed | -$7.87M |
|
404
Ligand Pharmaceuticals
LGND
$5.49B
| – | – |
-205,339
| Closed | -$13.1M |
|
405
Masco
MAS
$13.5B
| – | – |
-79,053
| Closed | -$2.71M |
|
406
Mattel
MAT
$3.76B
| – | – |
-55,089
| Closed | -$1.67M |
|
407
Nasdaq
NDAQ
$49.6B
| – | – |
-112,590
| Closed | -$2.54M |
|
|
NVEE
408
DELISTED
NV5 Global
NVEE
| – | – |
-617,328
| Closed | -$4.99M |
|
409
Occidental Petroleum
OXY
$59.3B
| – | – |
-25,100
| Closed | -$1.83M |
|
410
Penumbra
PEN
$12.5B
| – | – |
-67,335
| Closed | -$5.12M |
|
411
Pultegroup
PHM
$22.4B
| – | – |
-197,185
| Closed | -$3.95M |
|
412
Insulet
PODD
$9.75B
| – | – |
-262,560
| Closed | -$10.7M |
|
413
Post Holdings
POST
$3.56B
| – | – |
-180,645
| Closed | -$9.12M |
|
414
Power Integrations
POWI
$2.66B
| – | – |
-222,170
| Closed | -$7M |
|
415
Sabesp
SBS
$18.6B
| – | – |
-96,607
| Closed | -$173K |
|
416
Sherwin-Williams
SHW
$78B
| – | – |
-233,580
| Closed | -$21.5M |
|
417
iShares Silver Trust
SLV
$30.7B
| – | – |
-34,200
| Closed | -$622K |
|
|
SNCR
418
DELISTED
Synchronoss Technologies
SNCR
| – | – |
-21,140
| Closed | -$7.83M |
|
419
Spectrum Brands
SPB
$1.99B
| – | – |
-33,220
| Closed | -$4.57M |
|
420
Stewart Information Services
STC
$2B
| – | – |
-163,882
| Closed | -$7.29M |
|
|
THS
421
DELISTED
Treehouse Foods
THS
| – | – |
-122,885
| Closed | -$10.7M |
|
422
Toll Brothers
TOL
$12.2B
| – | – |
-111,200
| Closed | -$3.32M |
|
423
NCR Voyix
VYX
$982M
| – | – |
-431,950
| Closed | -$8.53M |
|
424
West Pharmaceutical
WST
$25.5B
| – | – |
-149,985
| Closed | -$11.2M |
|
|
BECN
425
DELISTED
Beacon Roofing Supply, Inc.
BECN
| – | – |
-292,446
| Closed | -$12.3M |
|
Similar funds
MSC
BC
FEG
HCM
OH
BCM
CCI
MCM
Castleark Management's Q4 2016 Portfolio in Review
As of Q4 2016, Castleark Management held 444 positions worth $3.14B, down 5.2% from $3.31B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Castleark Management withdrew a net $231M in Q4 2016, closing 73 positions and reducing 94 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $22.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Energy and Healthcare.
Against the trend, Castleark Management opened a new position in Morgan Stanley worth $32.9M.
- Castleark Management's largest Q4 2016 buy was Morgan Stanley: 779,714 shares worth $32.9M.
- Castleark Management added most to Middleby in Q4 2016, an estimated $25.9M increase.
- Castleark Management's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $43.4M.
- Castleark Management fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $22.8M.
- Castleark Management's ten largest holdings make up 16% of its $3.14B portfolio in Q4 2016.
- Castleark Management opened 72 new positions and closed 73 in Q4 2016.
- Castleark Management's portfolio value fell 5.2% quarter-over-quarter to $3.14B.
Based on Castleark Management's 13F filing for Q4 2016, filed 15 Feb 2017.